AstraZeneca PLC (AZN:NASDAQ) closed at $185.48 on November 11, 2026, down 0.69% on the day. The stock trades 12.8% below its 52-week high of $212.71 and 20.9% above its 52-week low of $153.41. Over the past year, it gained 4.8%. AstraZeneca PLC is part of the Miscellaneous sector.
In 252 trading sessions since November 11, 2025, AZN closed higher on 122 days (48%). Its best day was October 30, 2026 (+7.02%) and its worst was August 3, 2026 (-6.88%). It never moved 10% or more in a single session.
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its revenue.
Find more stocks like AZN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.